Seeking Alpha

  Biogen Idec Inc. - NASDAQ

10/21/2014, 3:46 AM ET
  • Michael Bryant | Send Message 14 Oct 2012

    "Biogen (BIIB) says new look at data bolsters oral MS drug." BIIB is a winner. Buy and hold.
      BIIB vs. ETF Alternatives
      Company Description
      Biogen Idec Inc, is a biotechnology company that discovers, develops, manufactures and markets therapies for the treatment of multiple sclerosis (MS) and other autoimmune disorders, neurodegenerative diseases and hemophilia.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States